compound introduction
Cabozantinib (XL184, BMS-907351)是一种有效的VEGFR2抑制剂，靶向作用于VEGFR2和c-Met时，IC50为0.035 nM ，也有效抑制c-Met、 Ret、 Kit、Flt-1/3/4、Tie2和AXL，IC50分别为1.3 nM， 4 nM， 4.6 nM， 12 nM/11.3 nM/6 nM， 14.3 nM and 7 nM。A potent VEGFR2 and Met inhibitor Cabozantinib (XL184, BMS-907351) is a potent VEGFR2 inhibitor with IC50 of 0.035 nM and also inhibits c-Met, Ret, Kit, Flt-1/3/4, Tie2, and AXL with IC50 of 1.3 nM, 4 nM, 4.6 nM, 12 nM/11.3 nM/6 nM, 14.3 nM and 7 nM, respectively. A potent VEGFR2 and Met inhibitor
